The healthcare sector inched up just 0.1% at midday Tuesday, with all other sectors on the Australian bourse trading in the ...

Duchenne (SGT-003): 23 participants have been dosed in the INSPIRE DUCHENNE trial as of October 31, 2025; Solid expects to ...

The ASX 200 has reset to levels seen over a month ago, falling on broad weakness across sectors as the RBA remains hawkish on ...

The All Ordinaries Index (ASX: XAO) is sliding today, but don’t blame this rocketing ASX All Ords healthcare share. Here’s ...

Despite the S&P/ASX 200 Index dipping, Domino's is on the rise with takeover rumors swirling, DroneShield is climbing on a big new contract, and Imricor is making waves with a breakthrough medical ...

Solid Biosciences ( ($SLDB) ) has released its Q3 earnings. Here is a breakdown of the information Solid Biosciences presented to its investors.

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( ($AU:IMR) ) just unveiled an announcement. Imricor Medical Systems, Inc.

Motorists are being alerted to an important date that’s fast-approaching. On social media, the DVLA Personalised Registration ...

First-in-Human Phase 1 data for allogeneic CAR-T cell therapy for NHL to be featured in oral session ...

Gilead Sciences, Inc. and Kite, a Gilead Company, will present 21 abstracts, including 5 oral presentations, during the 67th American Society of Hematology (ASH) Annual Meeting and Exposition ...

Sarepta Therapeutics, Inc. , the leader in precision genetic medicine for rare diseases, today reported financial results for the third quarter of 2025 and the completion of ESSENCE, its global, Phase ...

Imricor Medical Systems, Inc. (ASX: IMR), a company striving to make interventional medical procedures better and safer through real-time MRI guidance, has announced a significant milestone. In ...